BioAge Labs, Inc. (BIOA) stock
BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.10−0.12 (-2.30%)
Close on Nov 17, 2026Market cap $234.07MP/E –Yield –
BioAge Labs total assets
Total assets on the balance sheet at the end of each period.
BioAge Labs's total assets was $396.93M at Jun 30, 2026. For fiscal 2025 it was $294.89M, down 17.7% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $294.89M | -17.7% |
| FY2024 | Dec 31, 2024 | $358.23M | +1281.9% |
| FY2023 | Dec 31, 2023 | $25.92M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $396.93M | +23.2% |
| Q1 FY2026 | Mar 31, 2026 | $397.65M | +15.7% |
| Q4 FY2025 | Dec 31, 2025 | $294.89M | -17.7% |
| Q3 FY2025 | Sep 30, 2025 | $305.09M | -9.6% |
| Q2 FY2025 | Jun 30, 2025 | $322.15M | +1142.7% |
| Q1 FY2025 | Mar 31, 2025 | $343.84M | – |
| Q4 FY2024 | Dec 31, 2024 | $358.23M | – |
| Q3 FY2024 | Sep 30, 2024 | $337.38M | – |
| Q4 FY2023 | Dec 31, 2023 | $25.92M | – |
See a number that looks wrong?